You can buy or sell KZIA and other stocks, options, ETFs, and crypto commission-free!
Kazia Therapeutics Ltd. engages in the pharmaceutical drug research and development. Its pipeline includes two clinical-stage drug development candidates such as GDC-0084, and Cantrixil. Read More The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Sydney, New South Wales (NSW)
52 Week High
52 Week Low